Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics Inks Purchasing Deal with Premier

NEW YORK (GenomeWeb) – NeoGenomics today announced a three-year national group purchasing agreement with Premier to provide the healthcare alliance's members with full access to NeoGenomics' menu of oncology testing services. 

The deal makes Ft.Myers, Florida-based NeoGenomics the first specialized oncology reference laboratory to be a preferred in-network lab option for all Premier member hospitals, cancer centers, pathology groups, and oncology physician providers, the company said. Premier is a healthcare group purchasing organization composed of about 3,600 hospitals and 12,000 other provider members. 

The agreement gives its members access to NeoGenomics' services such as the next-generation sequencing-based NeoType Cancer Profiles. The NeoType tumor-specific profiling menu was recently expanded to include profiles for head and neck tumors, pancreatic cancer, liver cancer, sarcoma, and cancers of unknown primary. A complete analysis of somatic mutations in BRCA1 and 2 are now also a part of breast, ovarian, and pancreatic cancer profiling. 

NeoGenomics' shares on the Nasdaq rose about 6 percent to $6.29 in morning trading today.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.